Bluejay Diagnostics, Inc.: Business Overview, Financials & Competitive Analysis
Bluejay Diagnostics operates as a medical diagnostics company offering the Symphony technology platform, which consists of an analyzer and single-use protein detection cartridges designed to provide measurements of ke...
Cyborg Score thesis
Early-stage diagnostics platform with meaningful clinical application potential, but regulatory and commercial hurdles require...
Read the full analyst-debate transcript →Get the Latest Bluejay Diagnostics, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeBluejay Diagnostics, Inc. Overview
Pro stress-test →Bluejay Diagnostics operates as a medical diagnostics company offering the Symphony technology platform, which consists of an analyzer and single-use protein detection cartridges designed to provide measurements of key diagnostic biomarkers found in blood. The company focuses on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient product for triage and monitoring of disease progression.
Strategic Profile
Pro stress-test →The company develops Symphony IL-6 tests for monitoring disease progression in critical care settings, with additional tests in development for myocardial infarction and congestive heart failure. In December 2025, Bluejay completed commercial-scale production of both polyclonal and monoclonal antibodies targeting interleukin-6 (IL-6), with both meeting internal performance criteria for use in Symphony cartridge manufacturing.
Competitive Landscape
Pro stress-test →Bluejay competes in the point-of-care diagnostics market against companies focused on rapid clinical chemistry and sepsis/critical care diagnostics. Key competitors include CytoVale and SphingoTec, both developing rapid diagnostic platforms for similar clinical settings. Bluejay's differentiation rests on its proprietary Symphony microfluidics technology and focus on IL-6 and cardiac biomarkers, though the company remains pre-dominant commercialization relative to more established clinical diagnostics firms.
Industry Context
Bluejay Diagnostics, Inc. operates in In-Vitro Diagnostics.
Key facts
Founded: 2015 · Headquarters: Acton, Massachusetts, US · Employees: 9-13 · Revenue: $5 million (2026)